You have read all your free articles, to continue reading subscribe to read the rest of this content.
Ilya Pharma has secured a total of 5.3 million EUR in funding from the European Innovation Council (EIC) Accelerator program of blended financing. The funds will enable Ilya Pharma to accelerate a Phase II Trial of its lead drug candidate ILP100 which has the potential to heal problematic non-heaAlready a…
For the second time, Umeå Biotech Incubator (UBI) has been granted funding from the Family Erling-Persson Foundation, this time the sum is 17 million SEK. Results from previous allocations are positive, the incubator's external capital to start-up companies has increased with over 200 percent beAlready a subscriber Login You have…
Umeå Biotech Incubator (UBI) has been named the only incubator in the Nordic region to once again be granted funding from the prestigious Erling Persson Family Foundation. UBI is being granted SEK 10 million between 2020-2022 to help researchers commercialise their ideas for the greater benefit Already a subscriber Login…
Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca. Shares in AstraZeneca fell 1.2 percent by 0800 GMT on Friday following the news. Pfizer is in the middle of a…
